1. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
- Author
-
Agnelli L., Mereu E., Pellegrino E., Limongi T., Kwee I., Bergaggio E., Ponzoni M., Zamò A., Iqbal J., Neri A., Chan W. C., Bertoni F., Inghirami G., Piva R., European T. Cell Lymphoma Study G.r.o.u.p. Barreca A., Cuccuru G., Medico E., Spaccarotella E., Scarfò I., Fornari A., Ferreri C., Novero D., Chilosi M., Facchetti F., Lonardi S., De Chiara A., Fulciniti F., Doglioni C., Todoerti K., Falini B., Tiacci E., Van Loo P., Tousseyn T., De Wolf Peeters C., Geissinger E., Muller Hermelink H. K., Rosenwald A., Piris M. A., Rodriguez M. E., Boi M., PICCALUGA, PIER PAOLO, PILERI, STEFANO, AGOSTINELLI, CLAUDIO, Agnelli L., Mereu E., Pellegrino E., Limongi T., Kwee I., Bergaggio E., Ponzoni M., Zamò A., Iqbal J., Piccaluga P.P., Neri A., Chan W.C., Pileri S., Bertoni F., Inghirami G., Piva R., European T-Cell Lymphoma Study Group. Barreca A., Cuccuru G., Medico E., Spaccarotella E., Scarfò I., Fornari A., Ferreri C., Novero D., Chilosi M., Facchetti F., Lonardi S., De Chiara A., Fulciniti F., Doglioni C., Todoerti K., Agostinelli C., Falini B., Tiacci E., Van Loo P., Tousseyn T., De Wolf-Peeters C., Geissinger E., Muller-Hermelink H.K., Rosenwald A., Piris M.A., Rodriguez M.E., Boi M., Agnelli, L, Mereu, E, Pellegrino, E, Limongi, T, Kwee, I, Bergaggio, E, Ponzoni, Maurilio, Zamo, A, Iqbal, J, Piccaluga, Pp, Neri, A, Chan, Wc, Pileri, S, Bertoni, F, Inghirami, G, Piva, R, European T., Cell Lymphoma Study Grp, and Doglioni, Claudio
- Subjects
Lymphoma ,Bioinformatics ,Adult ,Biomarkers, Tumor ,Case-Control Studies ,Diagnosis, Differential ,Gene Expression Profiling ,Gene Expression Regulation, Neoplastic ,Humans ,Lymphoma, Large-Cell, Anaplastic ,Microarray Analysis ,Models, Statistical ,Molecular Diagnostic Techniques ,Predictive Value of Tests ,Prognosis ,Receptor Protein-Tyrosine Kinases ,Genes, Neoplasm ,Immunology ,Biochemistry ,Hematology ,Cell Biology ,GENE-EXPRESSION ANALYSIS ,Models ,hemic and lymphatic diseases ,PERIPHERAL T-CELL ,Diagnosis ,Anaplastic ,Anaplastic lymphoma kinase ,Anaplastic Lymphoma Kinase ,Anaplastic large-cell lymphoma ,Tumor ,Not Otherwise Specified ,Statistical ,CANCER ,Large-Cell ,NEOPLASMS ,Computational biology ,ABERRATIONS ,PROFILE ,CLASSIFICATION ,HODGKIN-LYMPHOMA ,KINASE ,medicine ,TRANSLOCATIONS ,Neoplastic ,business.industry ,Microarray analysis techniques ,Large cell ,medicine.disease ,Gene expression profiling ,Gene Expression Regulation ,Genes ,Differential ,Neoplasm ,Differential diagnosis ,business ,Biomarkers - Abstract
Anaplastic large-cell lymphomas (ALCLs) are a group of clinically and biologically heterogeneous diseases including the ALK(+) and ALK(-) systemic forms. Whereas ALK(+) ALCLs are molecularly characterized and can be readily diagnosed, specific immunophenotypic or genetic features to define ALK(-) ALCL are missing, and their distinction from other T-cell non-Hodgkin lymphomas (T-NHLs) remains controversial. In the present study, we undertook a transcriptional profiling meta-analysis of 309 cases, including ALCL and other primary T-NHL samples. Pathway discovery and prediction analyses defined a minimum set of genes capable of recognizing ALK(-) ALCL. Application of quantitative RT-PCR in independent datasets from cryopreserved and formalin-fixed paraffin-embedded samples validated a 3-gene model (TNFRSF8, BATF3, and TMOD1) able to successfully separate ALK(-) ALCL from peripheral T-cell lymphoma not otherwise specified, with overall accuracy near 97%. In conclusion, our data justify the possibility of translating quantitative RT-PCR protocols to routine clinical settings as a new approach to objectively dissect T-NHL and to select more appropriate therapeutic protocols. (Blood. 2012;120(6):1274-1281) Anaplastic large-cell lymphomas (ALCLs) are a group of clinically andbiologically heterogeneous diseases including the ALK(+) and ALK(-) systemicforms. Whereas ALK(+) ALCLs are molecularly characterized and can be readilydiagnosed, specific immunophenotypic or genetic features to define ALK(-) ALCLare missing, and their distinction from other T-cell non-Hodgkin lymphomas(T-NHLs) remains controversial. In the present study, we undertook atranscriptional profiling meta-analysis of 309 cases, including ALCL and otherprimary T-NHL samples. Pathway discovery and prediction analyses defined aminimum set of genes capable of recognizing ALK(-) ALCL. Application ofquantitative RT-PCR in independent datasets from cryopreserved and formalin-fixedparaffin-embedded samples validated a 3-gene model (TNFRSF8, BATF3, and TMOD1)able to successfully separate ALK(-) ALCL from peripheral T-cell lymphoma nototherwise specified, with overall accuracy near 97%. In conclusion, our datajustify the possibility of translating quantitative RT-PCR protocols to routineclinical settings as a new approach to objectively dissect T-NHL and to selectmore appropriate therapeutic protocols
- Published
- 2012